Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Trials
2 recruiting trials for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT06947304
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Sponsor: Corcept TherapeuticsEnrolling: 81 location
RECRUITINGPhase 4NCT06374875
Fibrosis Lessens After Metabolic Surgery
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly...
Sponsor: Ali AminianEnrolling: 12020 locations